THE FIRST EXPERIENCE OF USING 320-SLICE CT PERFUSION IMAGING IN PROSTATE CANCER


Cite item

Full Text

Abstract

Introduction: Visualization of prostate cancer remains an actual problem in the urology and oncology. Purpose of the study: Evaluation of prostate cancer visualization using 320-slice perfusion computed tomography (PCT). Materials and methods: PCT results of 15 patients with suspected prostate cancer were evaluated. Studies were performed with the 320-slice spiral computed tomography Aquilion One (Toshiba, Japan). Perfusion of the prostate was calculated by the maximum gradient. Next to each perfusion map placed the zone of interest. For each area of interest the following indicators were taken into consideration: the average velocity of blood flow, normalized blood flow velocity, the difference of blood flow velocity in the contralateral areas of interest, the difference of the normalized blood flow velocity in the contralateral areas of interest. Differences between indicies and the results of histological examination for each zone of interest were evaluated by the variance analysis and by pairwise comparison with the Tukey’s criterion. Statistical significance of differences was assessed by the specialized computer language R v 3.2, using pROC packets. Results and conclusions: 180 biopsies were obtained. 19 ( prostate cancer Σ Gleason 6), 17 (prostate cancer Σ Gleason 7), 5 - (prostate cancer Gleason Σ 8), 7 (inflammation), 121 (no pathological), 11 (prostatic intraepithelial neoplasia (PIN)). The areas under the ROC curves for the studied parameters were: average blood flow rate 0.6343, normalized blood flow rate 0.5300, blood flow velocity difference in contralateral areas of interest 0.5875, normalized blood flow velocity difference in the contralateral areas of interest 0.6263. The obtained findings show a low sensitivity of the method in the detection of low-grade prostate cancer.

About the authors

N V SOSNOVSKII

Russian Scientific Center of Radiology and Surgical Technologies

Email: urologsosnovskiy@yandex.ru

E V ROZENGAUZ

Russian Scientific Center of Radiology and Surgical Technologies

Email: rozengaouz@yandex.ru

M I SHKOLNIK

Russian Scientific Center of Radiology and Surgical Technologies

Email: shkolnik_phd@mail.ru

D V NESTEROV

Russian Scientific Center of Radiology and Surgical Technologies

Email: cireto@gmail.com

A A ARZUMANOV

Russian Scientific Center of Radiology and Surgical Technologies

Email: Arzumanov72@gmail.com

References

  1. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность) // Под редакцией А.Д. Каприна, В.В. Старинского, Г.В. Петровой. - Москва, 2015.
  2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version1. 2016.http: // www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed March 15, 2016.
  3. Guidelines on Prostate Cancer. In: EAU Guidelines, edition presented at the 31th EAU Annual Congress, Munich 2016. http: // uroweb.org/guideline/prostate-cancer / #5 Accessed June 16, 2016.
  4. Prando A., Wallace S. Helical CT of prostate cancer: early clinical experience. AJR Am J Roentgenol. - 2000. - 175. - Р. 343-346.
  5. Golimbu M. et al. CAT scanning in staging of prostatic cancer // Urology. - 1981. - Vol. 18. - № 3. - P. 305-308.
  6. Engeler C.E., Wasserman N.F., Zhang G. Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives // Urology. - 1992. - Vol. 40. - № 4. - P. 346-350.
  7. Hricak H. et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging // Radiology. - 1987. - Vol. 162. - № 2. - P. 331-336.
  8. Emory T.H. et al. Use of CT to reduce understaging in prostatic cancer: comparison with conventional staging techniques // AJR Am J Roentgenol. - 1983. - Vol. 141. - № 2. - P. 351-354.
  9. Glazer D.I., Davenport M.S., Khalatbari S. et al. Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer // Abdominal Imaging, 2014.
  10. Jia J.B. et al. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology // European Journal of Radiology. - 2016. - Vol. 85. - № 1. - P. 261-267.
  11. Schieda N., Al-Dandan O., Shabana W., Flood T.A. , Malone S.C. Is primary tumor detectable in prostatic carcinoma at routine contrast-enhanced CT? Clinical Imaging. - 2015. - 39. - Р. 623-626.
  12. Elizabeth P. Ives, Melissa A. Burke, Pamela R. Edmonds et al. Perfusion of Prostate Cancer: Correlation with Whole-Mount Pathology. Clinical Prostate Cancer. - 2005. - Vol. 4. - № 2. Р. 17-21.
  13. Osimani M., Bellini D., Di Cristofano Cl. et al. Perfusion MDCT of Prostate Cancer: Correlation of Perfusion CT Parameters and Immunohistochemical Markers of Angiogenesis. AJR. - 2012. - 199. - Р. 1042-1048.
  14. Weinreb Jeffrey C., Jelle O. Barentsz, Peter L. Choyke et al. 2016 PI-RADS Prostate Imaging - Reporting and Data System: 2015. - Version 2. -European Urology. - 69(1). - Р. 16-40.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 SOSNOVSKII N.V., ROZENGAUZ E.V., SHKOLNIK M.I., NESTEROV D.V., ARZUMANOV A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).